Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China
· Delayed Price · Currency is CNY 16.97
-0.05 (-0.29%)
Apr 29, 2026, 3:04 PM CST
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 2.44B CNY in the quarter ending March 31, 2026, with 3.46% growth. This brings the company's revenue in the last twelve months to 7.91B, up 24.64% year-over-year. In the year 2025, Shijiazhuang Yiling Pharmaceutical had annual revenue of 7.83B with 20.24% growth.
Revenue (ttm)
7.91B
Revenue Growth
+24.64%
P/S Ratio
3.58
Revenue / Employee
675.80K
Employees
11,708
Market Cap
28.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.83B | 1.32B | 20.24% |
| Dec 31, 2024 | 6.51B | -3.81B | -36.88% |
| Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
| Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
| Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 4.92B |
| Livzon Pharmaceutical Group | 11.71B |
| Dizal (Jiangsu) Pharmaceutical | 801.14M |
| Humanwell Healthcare (Group) | 23.96B |
| Hubei Jumpcan Pharmaceutical | 5.90B |
| Kangmei Pharmaceutical | 5.25B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Chengdu Kanghong Pharmaceutical Group | 4.43B |